Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Enhancing cardiac reprogramming via synthetic RNA oligonucleotides

Molecular Therapy — Nucleic Acids(2020)10.1016/j.omtn.2020.10.034Source: DataRank Database

Enhancing cardiac reprogramming via synthetic RNA oligonucleotides is a research paper published in Molecular Therapy — Nucleic Acids (2020). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.75)OA: goldTopics (23)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Conrad P. Hodgkinson ORCID,Richard E. Pratt ORCID,JaeWoo Lee,Bruce A. Sullenger ORCID,Victor J. Dzau ORCID

Live enrichment

PubMed:33335792 PMC:PMC7723775 OpenAlex:https://openalex.org/W3096033627

National Heart, Lung, and Blood Institute

Grant: R01 HL131814-01A1

NHLBI NIH HHS

Grant: R01 HL131814

National Institutes of Health

Grant: 5R01HL131814-04

Novel Strategy for Enhancing miRNA As A Therapeutic for Cardiac Regeneration

FWCI

0.75

Citation Percentile

0.7%

Citation Trend

2021

2022

2023

2024

2026

goldLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S2162253120303462/pdf

publisherhttp://www.cell.com/article/S2162253120303462/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2162253120303462?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2162253120303462?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.omtn.2020.10.034

Fields of Study

CRISPR and Genetic EngineeringRNA Interference and Gene DeliveryFuel Cells and Related Materials0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

ReprogrammingOligonucleotideRNAComputational biologySynthetic biologyBiologyComputer scienceGeneticsDNAGeneCardiacinnate immunitymicroRNAsSynthetic RnasOriginal ArticleTherapeutics. PharmacologyRM1-950

Sustainable Development Goals

SDG 0: Good health and well-being